4-P-021

N/A

Report date: 2022/11/07 12:42:45

Base Information

Drug Name4-P-021
Drug Alias Name4P0214-P-021
ClassificationBiologics
Mechanisms of ActionC-X-C motif chemokine receptor 4 antagonists
TargetsC-X-C motif chemokine receptor 4
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFinland
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator Companies4P-Pharma LtdUniversity of BordeauxInstitut Pasteur De Lille
China Registration ClassN/A

Develop Information

Active CompaniesSanofi4P-Pharma Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A